Biotoxtech Co., Ltd. (KOSDAQ:086040)
South Korea · Delayed Price · Currency is KRW 1,999.00
-31.00 (-1.53%)
At close: Oct 30, 2026
Biotoxtech Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 52,476 | 47,017 | 41,341 | 32,631 | 37,292 | 32,717 |
Revenue Growth | 20.88% | 13.73% | 26.69% | -12.50% | 13.98% | 23.79% |
Gross Profit Gross Profit Growth | 7,385 | 5,802 | 2,499 | 1,862 | 12,429 | 10,509 |
Operating Income Operating Income Growth | -4,623 | -5,908 | -8,619 | -8,676 | 800.05 | 4,632 |
Net Income Net Income Growth | -3,995 | 1,163 | -6,427 | -4,878 | 2,725 | 7,114 |
Earnings Per Share EPS Growth | -259.69 | 74.00 | -417.02 | -316.14 | 185.86 | 444.28 |
EPS Growth | - | - | - | - | -58.17% | 148.20% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
South Korea South Korea Growth | 40,228 | 39,110 | 35,430 | 30,224 | 36,040 | 31,267 |
Overseas Overseas Growth | 12,248 | 7,907 | 5,911 | 2,407 | 1,252 | 1,451 |
Total Total Growth | 52,476 | 47,017 | 41,341 | 32,631 | 37,292 | 32,717 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 29,255 | 28,132 | 32,384 | 41,038 | 30,771 | 28,151 |
Total Debt Total Debt Growth | 68,359 | 62,500 | 63,049 | 61,591 | 49,140 | 27,049 |
Net Cash (Debt) Net Cash Growth | -39,104 | -34,367 | -30,665 | -20,553 | -18,369 | 1,102 |
Net Cash Growth | - | - | - | - | - | -71.82% |
Net Cash Per Share Net Cash Per Share Growth | -2528.47 | -2199.82 | -1744.94 | -1332.10 | -1255.03 | 71.58 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 5,540 | 6,636 | -7,120 | -16,238 | -1,309 | 4,346 |
Capital Expenditures CapEx Growth | -3,640 | -2,121 | -1,977 | -4,452 | -30,676 | -7,619 |
Free Cash Flow Free Cash Flow Growth | 1,901 | 4,515 | -9,097 | -20,691 | -31,985 | -3,273 |
Free Cash Flow Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 14.07% | 12.34% | 6.04% | 5.71% | 33.33% | 32.12% |
Operating Margin | -8.81% | -12.57% | -20.85% | -26.59% | 2.15% | 14.16% |
Pretax Margin | -11.24% | -0.74% | -21.34% | -36.26% | -1.73% | 19.82% |
Profit Margin | -7.61% | 2.47% | -15.55% | -14.95% | 7.31% | 21.74% |
FCF Margin | 3.62% | 9.60% | -22.00% | -63.41% | -85.77% | -10.00% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | 38.06 | - | - | 43.72 | 16.50 |
Forward PE | - | 25.30 | 25.30 | 25.30 | 25.30 | 25.30 |
P/FCF Ratio | 16.53 | 9.80 | - | - | - | - |
PS Ratio | 0.60 | 0.94 | 1.27 | 3.01 | 3.20 | 3.59 |